on (#76NTA)
During 2022-2024, a total of 13,507 clinical C. auris cases were reported to CDC, increasing from 2,882 in 2022 to 4,428 in 2023 and 6,197 in 2024, with smaller annual percentage increases over time.
Morbidity and Mortality Weekly Report (MMWR)
| Link | https://www.cdc.gov/mmwr/index.html |
| Feed | http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5 |
| Updated | 2026-06-30 20:00 |
on (#76JGC)
This report describes the number of drug overdose deaths that occurred in U.S. hotels and motels during 2022-2024.
on (#76JGB)
This report describes numbers of emergency department visits for suspected suicide attempts during 2021-2025.
on (#76DF5)
This report describes the public health response to a measles outbreak in a Texas community.
on (#76DF4)
This report describes a case of Legionnaires disease in an infant who drank formula prepared using a formula mixing device and tap water.
on (#761PA)
During 2010-2024, 54 U.S. jurisdictions reported 1,796 confirmed and probable brucellosis cases. A total of 71-165 cases were reported annually.
on (#76BRK)
This report describes 402 foodborne disease outbreaks caused by marine toxins were reported to FDOSS. These outbreaks resulted in 1,280 illnesses, 96 hospitalizations, and one death.
on (#768A4)
This report describes the risk posed by the current Ebola outbreak to the general U.S. population.
on (#768A3)
This report describes using a transmission model to project Ebola outbreak growth over three months.
on (#768A2)
This report describesa large outbreak of Bundibugyo virus diseaseidentifiedin the Democratic Republic of the Congoand Uganda.
on (#768A1)
This report describes using a transmission model to project Ebola outbreak growth over three months.
on (#768A0)
This report describes a large outbreak of Bundibugyo virus disease identified in the Democratic Republic of the Congo and Uganda.
on (#7689Z)
This report describes the risk posed by the current Ebola outbreak to the general U.S. population.
on (#7646G)
This report describes a large outbreak of Bundibugyo virus disease identified in the Democratic Republic of the Congo and Uganda.
on (#7646F)
This report describes the risk posed by the current Ebola outbreak to the general U.S. population.
on (#7646E)
This report describes using a transmission model to project Ebola outbreak growth over three months.
on (#763AM)
This report describes an outbreak of 39 cases of amatoxin mushroom poisoning in Northern California.
on (#763AK)
This report describes characteristics of patients who were hospitalized during a large measles outbreak in west Texas.
on (#75YA7)
This report describes characteristics of patients who were hospitalized during a large measles outbreak in west Texas.
on (#75YA6)
This report describes an outbreak of 39 cases of amatoxin mushroom poisoning in Northern California.
on (#75SHY)
This report describes sunburns among adults.
on (#75SHX)
This report describes an 8-month outbreak of carbapenemase-producing Enterobacterales in a long-term care facility in Ontario, Canada.
on (#75QQB)
This report describes operational guidance for public health investigation and response to mosquito-transmitted malaria in the United States.
on (#75MAV)
This report describes survey results from backyard flock owners' attitudes towards avian influenza.
on (#75MAT)
This report describes an increase in dengue cases reported during 2024.
on (#75FDR)
This report describes a fatal human case of highly pathogenic avian influenza in Washington.
on (#75FDQ)
This report describes 139 human exposures to cats infected with A(H5N1) in Los Angeles, California.
on (#75AKR)
This report describes an increase in eastern equine encephalitis in northern Vermont during 2023-2024.
on (#75AKQ)
This report describes 50 large tuberculosis outbreaks in 23 states during 2017-2023.
on (#755DY)
This report describes contact tracing following mpox exposures during commercial air travel.
on (#755DX)
This report describes flu vaccination coverage among nursing home residents and health care providers working in nursing homes.
on (#7504M)
This report describes two clusters of invasive of Haemophilus influenzae type b among adults with special risk factors in Alaska, Oregon, and Washington.
on (#7504K)
This report describes four cases of tetanus among children who had not received a primary tetanus toxoid-containing virus series before exposure.
on (#74YAE)
This report describes tetanus surveillance in the United States from 2009-2023
on (#74TWB)
This report describes severe illness associated with eating mushroom-containing chocolate products.
on (#74TWA)
This report describes the emergence of drug-resistant shigellosis in the United States during 2011-2023.
on (#74P4X)
This report describes influenza and COVID-19 vaccination coverage among health care providers in the United States during the 2024-25 respiratory virus season.
on (#74P4W)
This report describes an increase in reports linked to kratom-containing kava products in the United States from 2000-2025.
on (#74H0V)
This report describes vaccination coverage by age 2 among children born in 2021 and 2022.
on (#74H0T)
This report describes kratom-related exposures in the United States from 2015-2024.
on (#74BY9)
This report describes early detection and surveillance of the SARS-CoV-2 variant BA.3.2.
on (#746NH)
This report describes interim estimates of 2025-26 flu vaccine effectiveness in California during October 2025-January 2026.
on (#746NG)
This report describes interim estimates of 2025-26 seasonal flu vaccine effectiveness.
on (#746NF)
This report describes a measles outbreak in New Mexico in 2025.
on (#741ES)
This report describes exposures to chemical munitions during commercial fishing operations.
on (#741ER)
This report describes cases of congenital rubella in Florida.
on (#741EQ)
This report describes Kaposi sarcoma in an organ transplant recipient.
on (#73VVA)
This report describes a 2024 Salmonella outbreak linked to ice in a cooler at a county fair in Illinois
on (#73TPP)
This report describes respiratory virus activity in the United States during July 1, 2024-June 30, 2025.
on (#73TPN)
This report describes receipt of COVID-19 antiviral prescriptions among outpatients aged 65 and older from June 1, 2023-September 30, 2025.